HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies

被引：0

作者：

Scholl, Susy M. ^{[1
]}

Kamal, Maud ^{[1
]}

De Koning, Leanne ^{[1
]}

Kereszt, Attila ^{[2
]}

Jordanova, Ekaterina S. ^{[3
]}

Ungureanu, Sergiu ^{[4
]}

Berns, Els ^{[5
]}

Sastre, Xavier ^{[1
]}

机构：

[1] Inst Curie, Paris, France

[2] SeqOmics, Szeged, Hungary

[3] Ctr Gyneacol Oncol, Amsterdam, Netherlands

[4] Inst Oncol Moldova, Kishinev, Moldova

[5] Erasmus MC, Rotterdam, Netherlands

来源：

CURRENT PHARMACEUTICAL DESIGN | 2013年 / 19卷 / 08期

关键词：

Cervical cancer; HPV; vaccines; omics; targeted therapy; SQUAMOUS-CELL CARCINOMA; COLONY-STIMULATING FACTOR; PHASE PROTEIN MICROARRAYS; TUMOR-SUPPRESSOR PROTEIN; HUMAN-PAPILLOMAVIRUS DNA; GROWTH-FACTOR RECEPTOR; IGF-BINDING PROTEIN-3; C-MET; FACTOR-I; CONCURRENT CHEMORADIATION;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cervical cancer is the second most common malignancy among women worldwide. While more than 90% of cervical cancers carry one or more high risk HPV types, the exact relationship between HPV oncoproteins and signaling pathways alterations in cervical cancer remains to be clarified. Vaccines and targeted therapies are today considered of great potential for the improvement of patients' outcome. This review will focus on the interaction of HPV with cervical cancer pathway activations. Next generation high throughput screening technologies for molecular and protein profiling as well as innovative logistics, necessary for the implementation of the personalized care of cervical cancer patients will be discussed.

引用

页码：1379 / 1394

页数：16

共 50 条

[41] HPV related multiphaenotypic sinonasal carcinoma
Bundele, M.
Tang, Y. L.
VIRCHOWS ARCHIV, 2020, 477 : S313 - S313
[42] HPV-related oropharyngeal carcinoma
Costes, V.
ONCOLOGIE, 2015, 17 (5-6) : 250 - 255
[43] Diagnosis and management of HPV-related anal dysplasia
Greene, Michael D.
NURSE PRACTITIONER, 2009, 34 (05): : 46 - 51
[44] Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia
Geris, Jennifer M.
Amirian, E. Susan
Marquez-Do, Deborah A.
Guillaud, Martial
Dillon, Laura M.
Follen, Michele
Scheurer, Michael E.
CANCER PREVENTION RESEARCH, 2023, 16 (08) : 461 - 469
[45] Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study
Fischer, A. K.
Reuter-Jessen, K.
Schildhaus, H-U
Hugo, T.
Scheel, A. H.
Merkelbach-Bruse, S.
Heinmoeller, E.
Buettner, R.
Jasani, B.
Walbeck, J.
Rueschoff, J.
Middell, P.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 80 - 84
[46] The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
Tinelli, Andrea
Guido, Marcello
Zizza, Antonella
Pellegrino, Marcello
Greco, Marilena
Vergara, Daniele
Mynbaev, Ospan A.
Dell'Edera, Domenico
Malvasi, Antonio
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (08) : 1458 - 1465
[47] HPV-11, HPV-16 AND HPV-18 DNA-SEQUENCES IN CERVICAL SWABS FROM WOMEN WITH CERVICAL DYSPLASIA - PREVALENCE AND ASSOCIATED RISK OF PROGRESSION
HORDING, U
DAUGAARD, S
BOCK, JE
SEBBELOV, AM
NORRILD, B
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1991, 40 (01): : 43 - 48
[48] P53 polymorphism in HPV related cervical carcinoma; Relationship with time to invasion
Done, SJ
Arneson, NCR
OzHelik, H
Inoue, M
Duggan, MA
LABORATORY INVESTIGATION, 1999, 79 (01) : 115A - 115A
[49] Association of estradiol and HPV/HPV16 infection with the occurrence of cervical squamous cell carcinoma
Ding, Ling
Liu, Chunliang
Zhou, Qin
Feng, Meijuan
Wang, Jintao
ONCOLOGY LETTERS, 2019, 17 (03) : 3548 - 3554
[50] HUMAN PAPILLOMAVIRUS (HPV) IN VULVAR DYSPLASIA AND CARCINOMA IN-SITU
JUNGE, J
POULSEN, H
HORN, T
HORDING, U
LUNDVALL, F
APMIS, 1995, 103 (7-8) : 501 - 510

← 1 2 3 4 5 →